Literature DB >> 1750547

Regulation of glycolytic flux by coronary flow in guinea pig heart. Role of vascular endothelial cell glycocalyx.

J Suárez1, R Rubio.   

Abstract

Hemodynamic forces continuously act on endothelial cell lining of blood vessels. Blood flow, perfusing pressure, and shear stress are known to induce the release of bioactive substances from the endothelium. Furthermore, coronary flow (CF) is a well-known stimulant of myocardial contraction. Our concern was whether other Ca(2+)-dependent responses like glycolytic flux (Gf) were also CF dependent. For this purpose, isolated guinea pig hearts were perfused with a medium containing 5 mM 3-[3H]glucose, and the 3H2O released during perfusion was measured as an index of Gf. Changes in CF within the 3- to 25-ml/min range resulted in linear increase of Gf. This stimulatory effect of CF was also observed in K(+)-arrested hearts. In addition, increasing shear stress on addition of dextran to the perfusing solution (5% and 10% wt/vol), while keeping CF constant, also stimulated Gf. We hypothesized that endothelial cell membrane glycocalyx may act as sensor to this stimuli. Thus one would expect that substances acting on these structures (enzymes heparinase, hyaluronidase, or chondroitinase or the lectin concanavalin A) when added to the perfusate might inhibit the CF-induced Gf. The results showed that concanavalin A and heparinase inhibited the Gf-CF-induced response, whereas chondroitinase and hyaluronidase had no effect. These findings suggest that there may be a selective effect of these agents affecting the Gf response to CF. Our data suggest that CF stimulates Gf through shearing forces acting on specific endothelial glycocalyx component(s). Therefore, deformation of these components could result in the transduction of physical signals into release of chemical messengers that act on the biochemical machinery of underlining parenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750547     DOI: 10.1152/ajpheart.1991.261.6.H1994

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.

Authors:  D J Green; G O'Driscoll; B A Blanksby; R R Taylor
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

2.  Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release.

Authors:  I R Hutcheson; T M Griffith
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 3.  Advanced microscopy to elucidate cardiovascular injury and regeneration: 4D light-sheet imaging.

Authors:  Kyung In Baek; Yichen Ding; Chih-Chiang Chang; Megan Chang; René R Sevag Packard; Jeffrey J Hsu; Peng Fei; Tzung K Hsiai
Journal:  Prog Biophys Mol Biol       Date:  2018-05-09       Impact factor: 3.667

4.  Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals.

Authors:  E Czarnowska; E Karwatowska-Prokopczuk
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

5.  Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.

Authors:  A Beresewicz; E Czarnowska; M Maczewski
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

6.  Flow-Responsive Vascular Endothelial Growth Factor Receptor-Protein Kinase C Isoform Epsilon Signaling Mediates Glycolytic Metabolites for Vascular Repair.

Authors:  Kyung In Baek; Rongsong Li; Nelson Jen; Howard Choi; Amir Kaboodrangi; Peipei Ping; David Liem; Tyler Beebe; Tzung K Hsiai
Journal:  Antioxid Redox Signal       Date:  2017-09-21       Impact factor: 8.401

7.  Rat Liver Enzyme Release Depends on Blood Flow-Bearing Physical Forces Acting in Endothelium Glycocalyx rather than on Liver Damage.

Authors:  Julieta A Díaz-Juárez; Rolando Hernández-Muñoz
Journal:  Oxid Med Cell Longev       Date:  2017-02-28       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.